BRO Brown & Brown
Quality broker priced above its goodwill-heavy book's returns; the rally widens the premium again.
The story
Brown & Brown is a top-tier, capital-light insurance broker with high organic-growth discipline and roughly 29-32% operating margins. After the Accession deal the book is heavily goodwill, so reported ROE (9.7% trailing) understates the returns on tangible capital. Margins slipped to 29.1% on deal costs and a softening P&C pricing cycle, so integration has to deliver before ROE on the enlarged book rises.
Drivers are unchanged. Trailing ROE of 9.7% is close to the 10.2% normalized figure, which assumes modest synergy capture on the goodwill-inflated equity base. Book growth reflects retained earnings plus tuck-in M&A, with a terminal rate below the 4.98% risk-free rate. Beta stays just under the 0.9 industry anchor because broker fee income is not exposed to underwriting risk.
Value drivers
| Return on equity (normalized) | 10.2% |
| Book-value growth (Y1) | 6.5% |
| Terminal book growth | 4.5% |
| Beta | 0.82 |
| Failure probability | 0.5% |
| Cost of equity | 8.7% |
Valuation bridge
| PV of excess returns | 1.58B |
| PV of terminal excess | 3.41B |
| Equity value | 17.45B |
| ÷ shares → per share | $52.60 |
Projected excess returns on equity
| Yr | Book equity | ROE | Excess return | PV |
|---|---|---|---|---|
| 1 | 12.55B | 10.2% | 191.59M | 176.30M |
| 2 | 13.36B | 10.2% | 204.05M | 172.78M |
| 3 | 14.20B | 10.2% | 216.86M | 168.97M |
| 4 | 15.06B | 10.2% | 229.99M | 164.90M |
| 5 | 15.94B | 10.2% | 243.40M | 160.59M |
| 6 | 16.83B | 10.2% | 257.06M | 156.07M |
| 7 | 17.74B | 10.2% | 270.91M | 151.35M |
| 8 | 18.66B | 10.2% | 284.91M | 146.47M |
| 9 | 19.58B | 10.2% | 299.00M | 141.44M |
| 10 | 20.51B | 10.2% | 313.12M | 136.30M |
Key risks
- Accession integration or producer attrition erodes margins and leaves ROE stuck below 10%
- Softening P&C rate cycle slows organic growth and commission income
- Higher leverage and goodwill impairment risk if acquired revenue underperforms
Catalysts
- Margin recovery toward 32% as deal costs roll off and synergies show up
- Sustained mid-single-digit organic growth that proves the franchise holds through a soft market